ALC
Alcon, Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the following segments: Surgical and Vision Care. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner on 1945 and is headquartered in Fribourg, Switzerland.
Market Cap: 33 Billion
Primary Exchange: New York Stock Exchange
Website: http://www.alcon.com
Shares Outstanding: 492 Million
Float: 0
Dividend: 0.189999997615814 (0.0%)
Beta: 0.808337386222666
Sector: Health Technology
Industry: Medical Specialties
Ethical Flags
Longest drawdown: 338 trading days
From: 2019-05-10 To: 2020-02-19
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|---|---|---|---|---|---|---|---|
| 2021-04-30 | 2021-05-04 | 2021-05-03 | 2021-02-24 | 0.1 | Cash | |||
| 2020-05-12 | 2020-05-14 | 2020-05-13 | 2020-04-02 | 0.19 | Cash |
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|